Source link : https://newshealth.biz/health-news/new-data-back-crinecerfont-in-congenital-adrenal-hyperplasia/
Orlando, Florida — New data add to the evidence supporting use of crinecerfont for the treatment of congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency, in both adults and children. The latest findings from the company’s pediatric and adult phase 3 trials suggest that crinecerfont enables the dual goals of decreasing glucocorticoid dose to physiologic […]
The post New Data Back Crinecerfont in Congenital Adrenal Hyperplasia first appeared on News Health.
—-
Author : News Health
Publish date : 2025-05-15 20:30:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8